Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
19.11
-0.68 (-3.44%)
At close: Oct 30, 2026, 4:00 PM EST
19.20
+0.09 (0.47%)
Pre-market: Nov 2, 2026, 8:25 AM EST

Tandem Diabetes Care Revenue

Tandem Diabetes Care had revenue of $254.56M in the quarter ending June 30, 2026, with 5.77% growth. This brings the company's total for the last twelve months to $1.04B, up 3.96% year-over-year. In the year 2025, Tandem Diabetes Care had annual revenue of $1.01B with 7.93% growth. That makes Tandem Diabetes Care the 7,453rd largest company in the world by revenue and 1,769th in the United States.

Revenue (ttm)
$1.04B
Revenue Growth
+3.96%
P/S Ratio
1.28
Revenue / Employee
$416,567
Employees
2,500
Market Cap
1.33B

Revenue Chart

Revenue by Geography

  • United States 706.94M 69.7%
  • International 307.80M 30.3%
Fiscal year ended Dec 31, 2025 See the full Tandem Diabetes Care breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.01B74.53M7.93%
Dec 31, 2024940.20M192.49M25.74%
Dec 31, 2023747.72M-53.50M-6.68%
Dec 31, 2022801.22M98.42M14.00%
Dec 31, 2021702.80M203.97M40.89%
Dec 31, 2020498.83M136.53M37.68%
Dec 31, 2019362.31M178.44M97.05%
Dec 31, 2018183.87M76.27M70.88%
Dec 31, 2017107.60M23.35M27.72%
Dec 31, 201684.25M11.40M15.65%
Dec 31, 201572.85M23.13M46.51%
Dec 31, 201449.72M20.72M71.41%
Dec 31, 201329.01M26.53M1,072.00%
Dec 31, 20122.48M--
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Enovis2.30B
Integra LifeSciences Holdings1.66B
CONMED1.37B
Lumexa Imaging Holdings1.04B
Alphatec Holdings839.72M
NovoCure725.39M
Bioventus581.85M
Artivion471.47M
Revenue Rankings